StockNews.com Begins Coverage on Natural Alternatives International (NASDAQ:NAII)

StockNews.com began coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a report released on Monday. The brokerage set a “buy” rating on the stock.

Natural Alternatives International Price Performance

Shares of NASDAQ:NAII opened at $4.53 on Monday. The company has a current ratio of 2.56, a quick ratio of 1.59 and a debt-to-equity ratio of 0.11. Natural Alternatives International has a 12 month low of $4.13 and a 12 month high of $7.37. The company has a 50-day moving average price of $5.17 and a 200 day moving average price of $5.72. The company has a market cap of $28.09 million, a price-to-earnings ratio of -3.15 and a beta of 0.58.

Natural Alternatives International (NASDAQ:NAII) last announced its quarterly earnings results on Friday, September 27th. The company reported ($0.32) EPS for the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%. The business had revenue of $29.49 million during the quarter.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC boosted its position in Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 45,062 shares of the company’s stock after purchasing an additional 2,915 shares during the period. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 32.40% of the stock is currently owned by institutional investors and hedge funds.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.